financetom
Business
financetom
/
Business
/
Essex Property Trust Q3 Core FFO, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Essex Property Trust Q3 Core FFO, Revenue Rise
Nov 3, 2024 2:29 PM

05:35 PM EDT, 10/29/2024 (MT Newswires) -- Essex Property Trust ( ESS ) reported Q3 core funds from operations of $3.91 per diluted share late Tuesday, up from $3.78 a year earlier.

Analysts polled by Capital IQ expected an adjusted FFO of $3.31, if comparable.

Revenue in the three months ended Sept. 30 rose to $450.7 million from $419.2 million a year earlier.

Analysts surveyed by Capital IQ expected $445.3 million.

The company expects Q4 core FFO of $3.82 to $3.94 per diluted share. Analysts surveyed by Capital IQ expect adjusted FFO of $3.30, if comparable.

The company expects a full-year core FFO of $15.50 to $15.62 per diluted share versus previous guidance of $15.38 to $15.62. Analysts surveyed by Capital IQ expect an adjusted FFO of $13.53, if comparable.

The company expects full-year revenue for same-property growth on a cash basis of 3.1% to 3.4% versus previous guidance of 2.7% to 3.3%.

Price: 292.00, Change: -6.43, Percent Change: -2.15

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Beyond Oil Announces First Distribution Agreement in Vietnam
Beyond Oil Announces First Distribution Agreement in Vietnam
Sep 29, 2025
11:59 AM EDT, 09/29/2025 (MT Newswires) -- Beyond Oil ( BEOLF ) Monday announced its entry into the Vietnamese market through a new distribution agreement with Trang Anh Manufacturing and Trading. The distribution agreement, dated Sept. 26, 2025, marks Beyond Oil's ( BEOLF ) first commercial presence in Vietnam. It has an initial term of five years and requires the...
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says
Sep 29, 2025
11:38 AM EDT, 09/29/2025 (MT Newswires) -- Genmab's ( GMAB ) $8 billion offer for Merus (MRUS) represents a good deal that largely reflects the value of Merus' petosemtamab as a treatment for head and neck cancer, Truist Securities said in a Monday note. The all-cash transaction was announced earlier today, under which a Genmab ( GMAB ) unit will...
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
MoonLake's SLK Showed Limited Effectivesness in Recent Trials, Impacting Sales, Commercial Outlook, RBC Says
Sep 29, 2025
11:31 AM EDT, 09/29/2025 (MT Newswires) -- MoonLake Immunotherapeutics' ( MLTX ) SLK showed limited effectiveness in treating hidradenitis suppurativa which is likely to impact its sales and potential in other competitive markets like psoriatic arthritis, RBC Capital Markets said in a note Monday. SLK's phase 3 trial in hidradenitis suppurativa produced mixed results, with one study reaching statistical significance...
LGI Homes Foreclosure Rates 4x Higher Than FHA Average, Hunterbrook Report Alleges
LGI Homes Foreclosure Rates 4x Higher Than FHA Average, Hunterbrook Report Alleges
Sep 29, 2025
Shares of homebuilder LGI Homes Inc ( LGIH ) are trading lower Monday morning after a report by Hunterbrook Media accused the company of luring renters into buying homes they cannot afford through deceptive marketing and aggressive sales tactics. What To Know: The report, titled “Buyer’s Remorse,” alleges LGI Homes ( LGIH ) targets low-income individuals with ads for unrealistically...
Copyright 2023-2026 - www.financetom.com All Rights Reserved